You are here
IMI Stakeholder Forum 2017 | Open innovation
IMI Stakeholder Forum 2017
IMI encourages all stakeholders in health and medicines R&D to join the Stakeholder Forum: policy makers, academics and researchers, pharmaceutical industry and other sectors with an interest in health research, SMEs and mid-sized enterprises, patient representatives and regulators, representatives of other public-private partnerships and research-funding organisations.
Registration for the IMI Stakeholder Forum will open soon via the IMI website.
Wednesday 18 and Thursday 19 October 2017
Starting: 18 October at 13:00
Ending: 19 October at 17:00
Hotel Crowne Plaza Le Palace
Rue Gineste 3, Brussels, Belgium
The draft agenda will be available on IMI’s website shortly.
On the first day of the Stakeholder Forum we will be looking at IMI through the lens of open innovation, and discuss the results it is delivering through a dynamic, multi-stakeholder, collaborative innovation ecosystem.
On the second day, two parallel tracks will focus on examples of IMI’s open innovation in practice: patient involvement and microbiome research.
Nicola Bedlington | Secretary General, European Patient Forum
James Cusack | Director of Research, Autistica
Aled Edwards | Director and CEO of the Structural Genomics Consortium (SGC), Professor at the University of Toronto and Visiting Professor at the University of Oxford | IMI ULTRA-DD project
Iain Gillespie | Provost and Pro-Vice-Chancellors at the University of Leicester
Julian Isla | Founder and Chairman of the Dravet Syndrome Foundation | President of the Dravet Syndrome European Federation
Chantal Mathieu | Professor of Medicine and Program Director of Biomedical Sciences at the Katholieke Universiteit Leuven | IMI INNODIA project
Nino Mihokovic | Quality of Medicines Specialist, European Medicines Agency
Nathalie Moll | Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Anders Olauson | Honorary President, European Patient Forum
Ilaria Passarani | Head of Food and Health, BEUC
Stefan J. Scherer | Vice-President, Global Head Correlative Science, Novartis
Kristof Van Emelen | CSO – Product Development, ProDigest
Participation in this event is free of charge.Air Jordan IX 9 Shoes